CMR reveals myocardial damage from cardiotoxic oncologic therapies in breast cancer patients

被引：0
|
作者：
Johannes Kersten
Visnja Fink
Maria Kersten
Lisa May
Samuel Nunn
Marijana Tadic
Jens Huober
Inga Bekes
Michael Radermacher
Vinzenz Hombach
Wolfgang Rottbauer
Dominik Buckert
机构：
[1] University Hospital Ulm,Department for Internal Medicine II
[2] University Hospital Ulm,Department of Obstetrics and Gynecology
[3] Cantonal Hospital,undefined
[4] Department of Medical Oncology and Breast Center,undefined
来源：
The International Journal of Cardiovascular Imaging | 2024年 / 40卷
关键词：
Cancer therapy-related cardiac dysfunction (CTRCD); Cardiotoxicity; CMR; Feature tracking; Parametric mapping; Strain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：225 / 235
页数：10
相关论文
共 50 条
  • [31] Discussion for Oncologic Surveillance of Breast Cancer Patients After Lipofilling
    Otterburn, David M.
    AESTHETIC PLASTIC SURGERY, 2013, 37 (04) : 736 - 737
  • [32] Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: The role of irradiated heart volume
    Borger, Jacques H.
    Hooning, Maartje J.
    Boersma, Liesbeth J.
    Snijders-Keilholz, Antonia
    Aleman, Berthe M. P.
    Lintzen, Eelke
    Van Brussel, Sara
    Van der Toorn, Peter-Paul
    Alwhouhayb, Maitham
    Van Leeuwen, Flora E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04): : 1131 - 1138
  • [33] Cardiovascular risk factors in patients diagnosed with stage III or IV breast cancer treated with cardiotoxic and non-cardiotoxic regimens
    Yood, Marianne Ulcickas
    Beiderbeck, Annette
    Saltzgaber, Jacquelyn
    Oliveria, Susan A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S219 - S220
  • [34] An international survey of health care providers involved in the management of cancer patients exposed to cardiotoxic therapies.
    Dent, Susan Faye
    Sulpher, Jeffrey Allen
    Johnson, Christopher
    Turek, Michele
    Graham, Nadine A.
    Dattilo, Franco
    Lenihan, Daniel John
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] The prognostic value of cardiac biomarkers for predicting cardiac dysfunction in women treated for breast cancer with cardiotoxic therapies: a systematic review
    Boerman, Liselotte
    Berendsen, Annette
    Brandenbarg, Daan
    van der Vlist, Cato
    van der Meer, Peter
    de Bock, Geertruida H.
    Berger, Marjolein Y.
    EUROPEAN JOURNAL OF CANCER CARE, 2015, 24 : 41 - 41
  • [36] HYPERGLYCEMIA AND PATIENTS WITH CANCER-LIMITING THE IMPACT ON ONCOLOGIC THERAPIES AND QUALITY OF LIFE.
    Herbener, Laura
    Reimer, Nicole
    Quinn, Catherine
    ONCOLOGY NURSING FORUM, 2010, 37 (03) : E213 - E213
  • [37] Update Breast Cancer 2020 Part 5-Moving Therapies From Advanced to Early Breast Cancer Patients
    Lux, Michael P.
    Schneeweiss, Andreas
    Hartkopf, Andreas D.
    Mueller, Volkmar
    Janni, Wolfgang
    Belleville, Erik
    Stickeler, Elmar
    Thill, Marc
    Fasching, Peter A.
    Kolberg, Hans-Christian
    Untch, Michael
    Harbeck, Nadia
    Woeckel, Achim
    Thomssen, Christoph
    Schulmeyer, Carla E.
    Welslau, Manfred
    Overkamp, Friedrich
    Schuetz, Florian
    Lueftner, Diana
    Ditsch, Nina
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (04) : 469 - 480
  • [38] Aromatase inhibitors as adjuvant therapies in patients with breast cancer
    Coombes, RC
    Gibson, L
    Hall, E
    Emson, M
    Bliss, J
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5): : 309 - 311
  • [39] Nonadherence in Patients With Breast Cancer Receiving Oral Therapies
    Moore, Susan
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2010, 14 (01) : 41 - 47
  • [40] Oncologic Safety of Nipple-Sparing Mastectomy for Patients with Breast Cancer
    Ludwig, Kandice K.
    CURRENT BREAST CANCER REPORTS, 2021, 13 (01) : 35 - 41
12345